575 Results (Page 22 of 23)
China Markets Research Reports
China Lipid Disorder Therapeutics Market Analysis
The China Lipid Disorder Therapeutics Market was valued at $262.6 Mn in 2023 and is predicted to grow at a CAGR of 10.63% from 2023 to 2030, to $532.6 Mn by 2030. China Lipid Disorder Therapeutics Market is growing due to Increasing Healthcare Expenditure, Rising Prevalence of Dyslipidemia, and Expanding Treatment Guidelines. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd.Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
China Hemodialysis Equipment Market Analysis
The China Hemodialysis Equipment Market was valued at $1135.1 Mn in 2023 and is projected to grow at a CAGR of 9.1% from 2023 to 2023, to $2088.3 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Bain Medical Equipment, Guangdong Biolight Meditech, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Nipro Corp among others.
China Dental Fluoride Treatment Market Analysis
The China Dental Fluoride Treatment Market was valued at $1219.2 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $1761.9 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Colgate, Amway (China) Co. Ltd, Colgate-Palmolive Co, GlaxoSmithKline plc, Guangxi Aoqili Co. Ltd among others.
China Financial Assistance Programs Market Analysis
The China Financial Assistance Programs Market was valued at $2,278.1 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $6,477.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as CSPC Pharmaceuticals, Cardinal Health, Sinopharm Group Co Ltd, Merck, GSK, Johnson & Johnson, Novartis among others.
China Cold Pain Therapy Market Analysis
The China Cold Pain Therapy Market was valued at $177 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $297 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic pain disorders, technological advances in the industry, and changing consumer preferences. The industry is primarily dominated by players such as Meditech, Beijing Beike, Ossur, Shanghai Olympus, Pfizer, and Hisamitsu among others.
China Alopecia (Hair Loss) Therapeutics Market Analysis
The China Alopecia (Hair Loss) Therapeutics Market was valued at US $0.66 Bn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $1.31 Bn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, technological advancements and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Curollax, Lutronic, Pfizer among others.
China Periodontal Therapeutics Market Analysis
The China Periodontal Therapeutics Market was valued at $70.2 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $125.8 Mn by 2030. China Periodontal Therapeutics Market is growing due to Economic Growth and Rising Disposable Income, Technological Advancements, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Chartwell Pharmaceuticals LLC, ASA Dental, Steris-Hu-Friedy, Envista Holding Corporation, and Tokyo Chemical Industry Co. Ltd.
China Radiology Service Market Analysis
The China Radiology Service Market was valued at $321.6 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $919.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the China Radiology Service Market are Peking Union Medical College Hospital, Shanghai Huashan Hospital, Guangzhou Medical University Affiliated Cancer Hospital, Fudan University Shanghai Cancer Centre, Beijing Cancer Hospital, and Shanghai Renji Hospital, among others.
China Biobanks Market Analysis
The China Biobanks Market was valued at $6,168.90 Mn in 2023 and is predicted to grow at a CAGR of 10.30% from 2023 to 2030, to $12,252.90 Mn by 2030. The key drivers of this industry include government support, rising chronic diseases, and research and development initiatives. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
China Chronic Cough Therapeutics Market Analysis
China Chronic Cough Therapeutics Market was valued at $506 Mn in 2022 and is estimated to reach $1054 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include Hengan Group, Guangzhou Pharmaceutical Holdings, Shanghai Fosun Pharmaceutical, Beijing Tongrentang Group, Merck, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and GlaxoSmithKline.
China MRI Market Analysis
The China MRI Market was valued at $533.77 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $914.79 Mn by 2030. The key drivers of this industry include the rise in geriatric population, rising burden of chronic diseases, and technological advancements in MRI. The key players in the industry are GE Healthcare, Koninklijke Philips NV, Shenzhen Basda Medical Apparatus, and United Imaging Healthcare among others.
China Hypersomnia Therapeutics Market Analysis
The China Hypersomnia Therapeutics Market was valued at $59.80 Mn in 2023 and is predicted to grow at a CAGR of 2.50% from 2023 to 2030, to $71.08 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Teva, Takeda, Jiangsu Hengrui Medicine Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and Jazz Pharmaceuticals among others.
China Dental Implant Market Analysis
China Dental Implant Market was valued at $401.10 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $848.70 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, and technological advancements. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
China Head and Neck Cancer Therapeutics Market Analysis
The China Head and Neck Cancer Therapeutics Market was valued at $31.72 Mn in 2023 and is predicted to grow at a CAGR of 10.50% from 2023 to 2030, to $63.81 Mn by 2030. The key drivers of this industry include an aging population, advancement in treatment, and growth in the healthcare sector. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
China PET Scan Market Analysis
The China PET Scan Market was valued at $155.9 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $248.8 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the China PET Scan Market are GE Healthcare, Siemens Healthineers, Basda Medical, Toshiba, Schiller, and Hitachi, among others.
China Genomic Diagnostics Market Analysis
China Genomic Diagnostics Market was valued at $2,624.65 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $8,360.74 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, the aging population, and government support. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
China Compression Therapy Market Analysis
China Compression Therapy Market was valued at $99 Mn in 2022 and is estimated to reach $131 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry encompass entities such as Medi, Sigvaris, Juzo, Bauerfeind, Jobst, Amoena, LymphoCare, Activa Healthcare, Variteks, and Ofa Bamberg.
China Bio-implant Market Analysis
The China Bio-implant Market was valued at $5225.2 Mn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $8612.5 Mn by 2030. The China Bio-implant Market is growing due to Growing Medical Tourism, Rising Chronic Disease Prevalence, Urbanization, and Lifestyle Changes. The market is primarily dominated by players such as MicroPort, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Boston Scientific Corporation, and Johnson & Johnson Services.
China Mouth Ulcer Therapeutics Market Analysis
The China Mouth Ulcer Therapeutics Market was valued at $122.2 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $176.6 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Allergan, AstraZeneca, Hikma Pharmaceuticals PLC among others.
China Exosome Research Market Analysis
The China Exosome Research Market was valued at $13.6 Mn in 2023 and is projected to grow at a CAGR of 17.5% from 2023 to 2023, to $42 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Clara Biotech, RoosterBio, Florica Therapeutics, BeiGene, Fosun Pharma, Sinopharm, Sinovac Biotech among others.
China Bariatric Surgery Devices Market Analysis
The China Bariatric Surgery Devices Marketwas valued at $213.8 Mn in 2023 and is projected to grow at a CAGR of 6.7% from 2023 to 2023, to $336.7 Mn by 2030. The demand for bariatric operations is anticipated due to increasing demand for minimally invasive surgeries, technological advancements, rising awareness about bariatric surgery, rising incidence of adult obesity, increase in sedentary lifestyle, increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, are driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are MicroTech Medical, Zhejiang Xlzt Med Co, Beijing Rixin Technology Co, Medtronic, B. Braun among others.
China Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The China Cough Hypersensitivity Syndrome Therapeutics Market was valued at $0.651 Bn in 2022 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $1.153 Bn by 2030. The key drivers of this industry include the increasing prevalence of Cough Hypersensitivity Syndrome, the development of advanced therapeutics, and expanding healthcare infrastructure. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Merck, Novartis, AstraZeneca, and Pfizer among others.
China CT Scan Market Analysis
China CT Scan Market was valued at $370.59 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $693.71 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, increasing population and aging, and integration of AI and machine learning. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
China Mental Health Apps Market Analysis
The China Mental Health Apps Market was valued at $498.4 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $1469.18 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, government support, and rising incidences. The industry is primarily dominated by players such as Happify, HeadSpace, Pacifica, and Now Meditation among others.
China Constipation Therapeutics Market Analysis
China Constipation Therapeutics Market was valued at $1463 Mn in 2022 and is estimated to reach $2708 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Pfizer, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Merck & Co., Novartis, Sanofi, Takeda, Shanghai Fosun Pharmaceutical, and Beijing Tongrentang.
